Comparative Effectiveness Research Toolkit

The establishment of the nonprofit, public-private entity, the Patient-Centered Outcomes Research Institute (PCORI), in the new health reform law has elevated the visibility and importance of comparative effectiveness research (CER) in the health care system. But as CER takes on an increasingly influential role in informing coverage decisions and the treatments that patients receive, many questions remain about how to ensure that the comparative evidence that is developed is both scientifically valid and communicated in such a way that it can be applied appropriately.
To help you and your colleagues understand CER and some of the important questions under discussion, the National Pharmaceutical Council has developed this Comparative Effectiveness Research Tool Kit.
This CER Tool Kit includes the following materials:
- The Patient-Centered Outcomes Research Institute: Methodology Committee Resource Guide, with biographical information about the PCORI methodology committee members and background information on the different types of CER;
- The Patient-Centered Outcomes Research Institute Resource Guide, which includes biographical sketches of the PCORI board of governors, a history of CER and the law that created PCORI, and additional resouces;
- Demystifying Comparative Effectiveness Research: A Case Study Learning Guide (full report and executive summary), which provides guidance to help stakeholders understand the three primary types of CER and includes a checklist on how to evaluate a CER study and assess its applicability to a particular health care decision;
- Framing the Debate/Untangling the Potential Impact of Comparative Effectiveness Research on Innovation, which explores how CER investments will shape incentives for bringing new therapies to market;
- National Institute for Health and Clinical Excellence (NICE): How Does It Work and What Are the Implications for the U.S.? (executive summary), which examines the U.K.’s health technology assessment organization and discusses key learnings from this organization; and
- The Good ReseArch for Comparative Effectiveness (GRACE) principles, which address good practice for the design, conduct, analysis, and reporting of observational studies of comparative effectiveness.
Additional copies of the materials can be ordered through NPC’s website.
CER Tweets of the Week (June 3-7, 2013)
The Patient-Centered Outcomes Research Institute (PCORI) generated buzz on Twitter this week with the announcement of the winners of the PCORI...E.V.I.dently May 2013
Message From NPCThe Role of Pharmaceuticals in Health Insurance ExchangesOne of the most pressing issues in the implementation of the Affordable Care...Why Real-World Evidence Matters
National Pharmaceutical Council Director of Comparative Effectiveness Research Dr. Jennifer Graff explains the concept of real-world evidence (what...CER Collaborative: Providing the Tools for Better Formulary Decisions
National Pharmaceutical Council Chief Science Officer Robert Dubois, MD, PhD, and Director of Comparative Effectiveness Research Jennifer Graff,...NPC Welcomes Dr. Bryan Luce as PCORI Chief Science Officer
WASHINGTON, DC (April 24, 2013) The National Pharmaceutical Council today welcomed the news that the Patient-Centered Outcomes Research Institute (...NPC Survey Shows Health Care Stakeholders Continue to Show Optimism About Future Role of Comparative Effectiveness Research
(Washington, DC, March 19, 2013)—As the implementation of the Affordable Care Act (ACA) picks up speed, a new survey shows that health care...National Pharmaceutical Council Welcomes Amgen as Its Newest Member
Washington, D.C. (January 16, 2013)—The National Pharmaceutical Council (NPC) today welcomed biotechnology pioneer Amgen as its newest member. Joshua...National Pharmaceutical Council Comments on PCORI Approval of Research Methodology Standards
Washington, DC (November 19, 2012)—The National Pharmaceutical Council (NPC) today commented on the Patient-Centered Outcomes Research Institute’s (...The State of CER and the Environment for Health Care Decision Making
This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (CER), “The State of Comparative...Keeping Our Eye on the CER Ball
Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington will focus on the federal budget....Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?
A growing chorus of voices is publicly sharing data on the effectiveness of treatment options, but one viewpoint has long been shut out of key areas...Living Up to Its Name? The Role of Patient-Centered Research
Anyone who has ever received bad news from his or her health care provider or held a loved one’s hand when a diagnosis was delivered can understand...Why Real-World Evidence Matters
National Pharmaceutical Council Director of Comparative Effectiveness Research Dr. Jennifer Graff explains the concept of real-world evidence (what...Challenges With Real-World Evidence
National Pharmaceutical Council Chief Science Officer Dr. Robert Dubois explains that how a drug might-or might not—work in a clinical trial could be...Using Distributed Data Networks to Understand Heterogeneity in Real-World Data
Kimberly Westrich, director of health services research at the National Pharmaceutical Council, explains how large observational datasets like...CER Collaborative: Assessing Evidence and Informing Decision-Making
National Pharmaceutical Council (NPC) Director of Comparative Effectiveness Research Dr. Jennifer Graff discusses an initiative designed to help...CER Tweets of the Week (June 3-7, 2013)
The Patient-Centered Outcomes Research Institute (PCORI) generated buzz on Twitter this week with the announcement of the winners of the PCORI...CER Collaborative: Providing the Tools for Better Formulary Decisions
National Pharmaceutical Council Chief Science Officer Robert Dubois, MD, PhD, and Director of Comparative Effectiveness Research Jennifer Graff,...CER Tweets of the Week (Apr. 29 – May 3, 2013)
Conversations on Twitter about evidence and comparative effectiveness research highlighted the Agency for Healthcare Research and Quality’s call for...The Role of Pharmaceuticals in Health Insurance Exchanges
As part of the implementation of the Affordable Care Act, a series of state health insurance exchanges are being established across the United States...Research
Principles for Planning and Conducting Comparative Effectiveness Research
A group of leading researchers developed a set of 13 best practice principles that could help to...Virginia Health Outcomes Partnership: A Demonstration Project
This report documents the Virginia Health Outcomes P
Effectiveness of Interventions to Improve Patient Compliance: A Meta-analysis
This statistical analysis of 153 studies to explore different approaches of how to improve patient...- 1 of 20
- >
Commentary & Testimony
The State of CER and the Environment for Health Care Decision Making
Keeping Our Eye on the CER Ball
Leveling the Playing Field? Could a Landmark Decision Alter the CER Communications Landscape?
Living Up to Its Name? The Role of Patient-Centered Research
The Risks of Standardized Health Care